BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21689832)

  • 1. Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: four cases.
    Del Tredici K; Duda JE
    J Neurol Sci; 2011 Nov; 310(1-2):100-6. PubMed ID: 21689832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathology of Lewy body disorders.
    Kövari E; Horvath J; Bouras C
    Brain Res Bull; 2009 Oct; 80(4-5):203-10. PubMed ID: 19576266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease.
    Del Tredici K; Hawkes CH; Ghebremedhin E; Braak H
    Acta Neuropathol; 2010 Jun; 119(6):703-13. PubMed ID: 20229352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.
    Dickson DW; Fujishiro H; DelleDonne A; Menke J; Ahmed Z; Klos KJ; Josephs KA; Frigerio R; Burnett M; Parisi JE; Ahlskog JE
    Acta Neuropathol; 2008 Apr; 115(4):437-44. PubMed ID: 18264713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fulminant Lewy body disease.
    Momjian-Mayor I; Pizzolato GP; Burkhardt K; Landis T; Coeytaux A; Burkhard PR
    Mov Disord; 2006 Oct; 21(10):1748-51. PubMed ID: 16830307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in lewy body disease.
    Fumimura Y; Ikemura M; Saito Y; Sengoku R; Kanemaru K; Sawabe M; Arai T; Ito G; Iwatsubo T; Fukayama M; Mizusawa H; Murayama S
    J Neuropathol Exp Neurol; 2007 May; 66(5):354-62. PubMed ID: 17483692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.
    Jellinger KA
    Mov Disord; 2012 Jan; 27(1):8-30. PubMed ID: 22081500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autonomic involvement in Parkinson's disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers.
    Cersosimo MG; Benarroch EE
    J Neurol Sci; 2012 Feb; 313(1-2):57-63. PubMed ID: 22001247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lewy pathology and neurodegeneration in premotor Parkinson's disease.
    Del Tredici K; Braak H
    Mov Disord; 2012 Apr; 27(5):597-607. PubMed ID: 22508278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parkinson's disease: the distribution of Lewy bodies in the peripheral autonomic nervous system].
    Wakabayashi K
    No To Shinkei; 1989 Oct; 41(10):965-71. PubMed ID: 2557873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study.
    Minguez-Castellanos A; Chamorro CE; Escamilla-Sevilla F; Ortega-Moreno A; Rebollo AC; Gomez-Rio M; Concha A; Munoz DG
    Neurology; 2007 Jun; 68(23):2012-8. PubMed ID: 17548551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model.
    Kingsbury AE; Bandopadhyay R; Silveira-Moriyama L; Ayling H; Kallis C; Sterlacci W; Maeir H; Poewe W; Lees AJ
    Mov Disord; 2010 Nov; 25(15):2508-15. PubMed ID: 20818670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical reappraisal of current staging of Lewy-related pathology in human brain.
    Jellinger KA
    Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
    Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
    No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dementia with Lewy bodies.
    McKeith IG; Burn DJ; Ballard CG; Collerton D; Jaros E; Morris CM; McLaren A; Perry EK; Perry R; Piggott MA; O'Brien JT
    Semin Clin Neuropsychiatry; 2003 Jan; 8(1):46-57. PubMed ID: 12567332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra.
    Yamamoto S; Fukae J; Mori H; Mizuno Y; Hattori N
    Neurosci Lett; 2006 Apr; 396(3):187-91. PubMed ID: 16386370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathologic analysis of Lewy-related α-synucleinopathy in olfactory mucosa.
    Funabe S; Takao M; Saito Y; Hatsuta H; Sugiyama M; Ito S; Kanemaru K; Sawabe M; Arai T; Mochizuki H; Hattori N; Murayama S
    Neuropathology; 2013 Feb; 33(1):47-58. PubMed ID: 22672612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory system pathology as a model of Lewy neurodegenerative disease.
    Duda JE
    J Neurol Sci; 2010 Feb; 289(1-2):49-54. PubMed ID: 19783257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders.
    Gelpi E; Navarro-Otano J; Tolosa E; Gaig C; Compta Y; Rey MJ; Martí MJ; Hernández I; Valldeoriola F; Reñé R; Ribalta T
    Mov Disord; 2014 Jul; 29(8):1010-8. PubMed ID: 24395122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.